Related Experiment Video
Updated: Mar 25, 2026

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
Asiatic Acid Ameliorates Indomethacin-Induced Gastric Ulcers in Rats Through Enhancement of TGF-β1
Abdulmohsin J Alamoudi1, Aya A Negm2, Hani Alturkistani3
1Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Abstract:
Use of non-steroidal anti-inflammatory drugs may be associated with peptic ulcers. Asiatic acid, the active ingredient of Centella asiatica, is well-known for its antioxidant, anti-inflammatory, and wound-healing effects. Therefore, the aim of the study was to investigate the potential gastroprotective effects of asiatic acid dissolved in orange oil against indomethacin-induced peptic ulcer in rats. Rats were assigned to six groups as follows: Group 1: orally received the vehicle of asiatic acid (0.5% CMC-Na) followed by the vehicle of indomethacin (0.5% DMSO, i.p.); Group 2: gavaged with CMC-Na followed by indomethacin (25 mg/kg, i.p.); Group 3: given orange oil (10 mg/kg) before indomethacin; Group 4: received oral asiatic acid (10 mg/kg) prior to indomethacin; Group 5: received oral asiatic acid (10 mg/kg) in orange oil (10 mg/kg) prior to indomethacin. Group 6: administered oral omeprazole (30 mg/kg) prior to indomethacin. Indomethacin induced reduced secretion of mucin, decreased levels of prostaglandin E2 (PGE2) and cyclooxygenase 1 (COX-1), heightened oxidative stress, and elevated levels of the proinflammatory mediators. Pretreatment with asiatic acid in orange oil almost restored the normal macroscopic and microscopic features, increased mucin secretion, increased COX-1 and PGE2 levels, and reduced oxidative stress and inflammation. Also, asiatic acid in orange oil significantly restored the levels of transforming growth factor β1 (TGF-β1) in the gastric tissue of rats. Asiatic acid in orange oil shows significant protective effects against indomethacin-induced gastric ulcers in rats. It improves both macroscopic and microscopic gastric mucosal features while restoring TGF-β1 levels, promoting tissue repair and healing.
More Related Videos
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...

